Global Digital Pathology Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023
Global Digital Pathology Market:
Global digital pathology market estimated to be valued US$ XX Mn in 2017 and poised to grow at CAGR of XX% over 2017-2023. Market for digital pathology is projected to reach US$ XX Mn by 2023.
Digital pathology can be defined as image-based information for the analysis, management, and interpretation of information achieved from a digital slide. In the field of pathology digital pathology is emerging technology. In the modern technology, specimen samples containing slides are converted into digital images for easy view, storage, analysis, and management of data collected and this enables the virtual microscopy, technology that enables posting image and transmission throughout the network connected. Data rich image helps in maintenance of patient health records electronically, therefore helps to compile and distribute the information to build the central database.
The growth of digital pathology globally anticipated grow at significant rate owing to the cost-effective procedures, ease of slides transportation virtually, and high efficient analysis of digital slides. Images can processed by computing algorithms, and can produce enhanced output. Furthermore, the time required for the diagnosis also reduced significantly through digital pathology techniques. In addition, low chances of errors in observation as well as interpretation make it the digital pathology as most significant technology in the pathology. Therefore, digital pathology showing increased adaptation rates over the conventional pathology treatments. Based on aforementioned factors digital pathology market is expected to show significant growth rate over the forecast period. However, lack of skilled personnel and unfavourable reimbursement policies are factors that expected to hamper the market growth.
Digital Pathology Market segmented based on product, type, application, end user, and region.
Based on product, digital pathology market segmented as:
Geographically, digital pathology market segmented into five regions they are North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is expected to grow at significant rate in digital pathology market owing to technological advancements and increase in R&D investments. Europe is expected to be another major market for the digital pathology owing to presence of large number of patient pool. Asia Pacific is expected to grow at the significant growth rate owing to adaptation rates of digital imaging in emerging economies, rising investments to adopt new technologies and devices, and the presence of untapped opportunities.Asia Pacific market expected to hav lucrative market growth opportunity owing to increase in incidence of cancer and growing demand for novel treatment options, developing healthcare facilities, and low laboratory expenses.
Some of the major players in global digital pathology are Perkin Elmer, Inc. (U.S.), Olympus Corporation (Japan), AstraZeneca plc (Definiens AG) (U.K.), Sectra AB (Sweeden), GE Healthcare (U.K.), Inspirata Co. (U.S.), The Danaher Corporation (U.S.), Koninklijke Philips N.V (Netherlands), F. Hoffmann-La Roche AG (Ventana Medical Systems) (Switzerland), Digipath Co. (U.S.), Carl Zeiss AG (Germany), 3D-Histech Ltd. (Hungary), Yokogawa Electronic Corporation (Japan), Quorum Technologies Inc. (Canada) and Hamamatsu Photonics K.K. (Japan) to name a few.
In March 2017, Danaher Corporation partened with Leeds Hospital to improve productivity and workflow
In June 2016, Royal Philips, acquired PathXL, a pathology, image-based analysis firm to develop integrated tools targeting applications in computational biology, education, workflow solutions, and image analytics
REPORT OUTLINE:
Global digital pathology market estimated to be valued US$ XX Mn in 2017 and poised to grow at CAGR of XX% over 2017-2023. Market for digital pathology is projected to reach US$ XX Mn by 2023.
Digital pathology can be defined as image-based information for the analysis, management, and interpretation of information achieved from a digital slide. In the field of pathology digital pathology is emerging technology. In the modern technology, specimen samples containing slides are converted into digital images for easy view, storage, analysis, and management of data collected and this enables the virtual microscopy, technology that enables posting image and transmission throughout the network connected. Data rich image helps in maintenance of patient health records electronically, therefore helps to compile and distribute the information to build the central database.
The growth of digital pathology globally anticipated grow at significant rate owing to the cost-effective procedures, ease of slides transportation virtually, and high efficient analysis of digital slides. Images can processed by computing algorithms, and can produce enhanced output. Furthermore, the time required for the diagnosis also reduced significantly through digital pathology techniques. In addition, low chances of errors in observation as well as interpretation make it the digital pathology as most significant technology in the pathology. Therefore, digital pathology showing increased adaptation rates over the conventional pathology treatments. Based on aforementioned factors digital pathology market is expected to show significant growth rate over the forecast period. However, lack of skilled personnel and unfavourable reimbursement policies are factors that expected to hamper the market growth.
Digital Pathology Market segmented based on product, type, application, end user, and region.
Based on product, digital pathology market segmented as:
- Scanners
- Software
- Communication Systems
- Storage Systems
- Human Digital Pathology
- Animal Digital Pathology
- Tele consultation
- Disease Diagnosis
- Drug Discovery
- Hospitals
- Pharmaceutical companies
- Academic institutes
Geographically, digital pathology market segmented into five regions they are North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is expected to grow at significant rate in digital pathology market owing to technological advancements and increase in R&D investments. Europe is expected to be another major market for the digital pathology owing to presence of large number of patient pool. Asia Pacific is expected to grow at the significant growth rate owing to adaptation rates of digital imaging in emerging economies, rising investments to adopt new technologies and devices, and the presence of untapped opportunities.Asia Pacific market expected to hav lucrative market growth opportunity owing to increase in incidence of cancer and growing demand for novel treatment options, developing healthcare facilities, and low laboratory expenses.
Some of the major players in global digital pathology are Perkin Elmer, Inc. (U.S.), Olympus Corporation (Japan), AstraZeneca plc (Definiens AG) (U.K.), Sectra AB (Sweeden), GE Healthcare (U.K.), Inspirata Co. (U.S.), The Danaher Corporation (U.S.), Koninklijke Philips N.V (Netherlands), F. Hoffmann-La Roche AG (Ventana Medical Systems) (Switzerland), Digipath Co. (U.S.), Carl Zeiss AG (Germany), 3D-Histech Ltd. (Hungary), Yokogawa Electronic Corporation (Japan), Quorum Technologies Inc. (Canada) and Hamamatsu Photonics K.K. (Japan) to name a few.
In March 2017, Danaher Corporation partened with Leeds Hospital to improve productivity and workflow
In June 2016, Royal Philips, acquired PathXL, a pathology, image-based analysis firm to develop integrated tools targeting applications in computational biology, education, workflow solutions, and image analytics
REPORT OUTLINE:
- The report provides granular level information about the market size, regional market share and forecast from 2017-2023
- The report covers in-detail insights about the competitor’s overview, key findings and their key strategies
- The Report Outlines drivers, restraints, challenges, and trends that are currently faced by the industry
- The report tracks recent innovations, key developments and startup’s details that are working in the industry
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
1. EXECUTIVE SUMMARY
2. GLOBAL DIGITAL PATHOLOGY MARKET INTRODUCTION
2.1. Global Digital Pathology Market– Taxonomy
2.2. Global Digital Pathology Market–Definitions
2.2.1. Product Type
2.2.2. Application
3. GLOBAL DIGITAL PATHOLOGY MARKET DYNAMICS
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Digital Pathology Market Dynamics – Factors Impact Analysis
3.6. Global Digital Pathology Market– Regulations
3.6.1. U.S
3.6.2. Europe
3.6.3. Japan
4. GLOBAL DIGITAL PATHOLOGY MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023
4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis
5. GLOBAL DIGITAL PATHOLOGY MARKET, BY PRODUCT TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023
5.1. Scanners
5.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Software
5.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Communication Systems
5.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Storage Systems
5.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
6. GLOBAL DIGITAL PATHOLOGY MARKET FORECAST, BY APPLICATION, 2012 - 2016 AND FORECAST, 2017 - 2023
6.1. Teleconsultation
6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Disease Diagnosis
6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Drug Discovery
6.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
7. GLOBAL DIGITAL PATHOLOGY MARKET FORECAST, BY TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023
7.1. Human Digital Pathology
7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Animal Digital Pathology
7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
8. GLOBAL DIGITAL PATHOLOGY MARKET FORECAST, BY END USER, 2012 - 2016 AND FORECAST, 2017 - 2023
8.1. Hospitals
8.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Pharmaceutical companies
8.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Academic institutes
8.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
9. GLOBAL DIGITAL PATHOLOGY MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 - 2023
9.1. North America
9.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Digital Pathology Market- Opportunity Analysis Index - By Product Type, By Application, By Type, By End User, and Region, 2017 – 2023
10. NORTH AMERICA DIGITAL PATHOLOGY MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
10.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1.1. Scanners
10.1.1.2. Software
10.1.1.3. Communication Systems
10.1.1.4. Storage Systems
10.1.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.2.1. Teleconsultation
10.1.2.2. Disease Diagnosis
10.1.2.3. Drug Discovery
10.1.3. Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.3.1. Human Digital Pathology
10.1.3.2. Animal Digital Pathology
10.1.4. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.4.1. Hospitals
10.1.4.2. Pharmaceutical companies
10.1.4.3. Academic institutes
10.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.1.5.1. U.S.
10.1.5.2. Canada
10.1.6. North America Digital Pathology Market- Opportunity Analysis Index - By Product Type, By Application, By Technology, By End User, and Country, 2017 – 2023
10.1.7. North America Digital Pathology Market Dynamics – Trends
11. EUROPE DIGITAL PATHOLOGY MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
11.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1.1. Scanners
11.1.1.2. Software
11.1.1.3. Communication Systems
11.1.1.4. Storage Systems
11.1.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.2.1. Teleconsultation
11.1.2.2. Disease Diagnosis
11.1.2.3. Drug Discovery
11.1.3. Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.3.1. Human Digital Pathology
11.1.3.2. Animal Digital Pathology
11.1.4. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.4.1. Hospitals
11.1.4.2. Pharmaceutical companies
11.1.4.3. Academic institutes
11.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.5.1. Germany
11.1.5.2. UK
11.1.5.3. France
11.1.5.4. Spain
11.1.5.5. Italy
11.1.5.6. Russia
11.1.5.7. Poland
11.1.5.8. Rest of Europe
11.1.6. Europe Digital Pathology Market- Opportunity Analysis Index - By Product Type, By Application Type, By Technology, By End User, and Country, 2017 – 2023
11.1.7. Europe Digital Pathology Market Dynamics – Trends
12. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
12.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1.1. Scanners
12.1.1.2. Software
12.1.1.3. Communication Systems
12.1.1.4. Storage Systems
12.1.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.2.1. Teleconsultation
12.1.2.2. Disease Diagnosis
12.1.2.3. Drug Discovery
12.1.3. Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.3.1. Human Digital Pathology
12.1.3.2. Animal Digital Pathology
12.1.4. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.4.1. Hospitals
12.1.4.2. Pharmaceutical companies
12.1.4.3. Academic institutes
12.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn),
Y-o-Y Growth (%), and Market Share (%)
12.1.5.1. Japan
12.1.5.2. China
12.1.5.3. India
12.1.5.4. ASEAN
12.1.5.5. Australia & New Zealand
12.1.5.6. Rest of Asia-Pacific
12.1.6. Asia-Pacific Digital Pathology Market- Opportunity Analysis Index - By Product Type, By Application Type, By Technology, By End User, and Country, 2017 – 2023
12.1.7. Asia-Pacific Digital Pathology Market Dynamics – Trends
13. LATIN AMERICA DIGITAL PATHOLOGY MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
13.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1.1. Scanners
13.1.1.2. Software
13.1.1.3. Communication Systems
13.1.1.4. Storage Systems
13.1.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.2.1. Teleconsultation
13.1.2.2. Disease Diagnosis
13.1.2.3. Drug Discovery
13.1.3. Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.3.1. Human Digital Pathology
13.1.3.2. Animal Digital Pathology
13.1.4. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.4.1. Hospitals
13.1.4.2. Pharmaceutical Companies
13.1.4.3. Academic Institutes
13.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.5.1. Brazil
13.1.5.2. Mexico
13.1.5.3. Argentina
13.1.5.4. Venezuela
13.1.5.5. Rest of Latin America
13.1.6. Latin America Digital Pathology Market- Opportunity Analysis Index - By Product Type, By Application Type, By Technology, By End User, and Country, 2017 – 2023
13.1.7. Latin America Digital Pathology Market Dynamics – Trends
14. MIDDLE EAST & AFRICA DIGITAL PATHOLOGY MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
14.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1.1. Scanners
14.1.1.2. Software
14.1.1.3. Communication Systems
14.1.1.4. Storage Systems
14.1.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.1.2.1. Teleconsultation
14.1.2.2. Disease Diagnosis
14.1.2.3. Drug Discovery
14.1.3. Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.1.3.1. Human Digital Pathology
14.1.3.2. Animal Digital Pathology
14.1.4. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.1.4.1. Hospitals
14.1.4.2. Pharmaceutical companies
14.1.4.3. Academic institutes
14.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.5.1. Gulf Cooperation Council (GCC) Countries
14.1.5.2. Israel
14.1.5.3. South Africa
14.1.5.4. Rest of MEA
14.1.6. MEA Digital Pathology Market- Opportunity Analysis Index - By Product Type, By Application, By Technology, By End User, and Country, 2017 – 2023
14.1.7. MEA Digital Pathology Market Dynamics – Trends
15. COMPETITION LANDSCAPE
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Drug & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Perkin Elmer, Inc. (U.S.)
15.2.2. Olympus Corporation (Japan)
15.2.3. Sectra AB (Sweeden)
15.2.4. GE Healthcare (U.K.)
15.2.5. Inspirata Co. (U.S.)
15.2.6. The Danaher Corporation (U.S.)
15.2.7. Koninklijke Philips N.V (Netherlands)
15.2.8. F. Hoffmann-La Roche AG (Switzerland)
15.2.9. Digipath Co. (U.S.)
15.2.10. Carl Zeiss AG (Germany)
15.2.11. 3D-Histech Ltd. (Hungary)
15.2.12. Yokogawa Electronic Corporation (Japan)
15.2.13. Quorum Technologies Inc. (Canada)
15.2.14. Hamamatsu Photonics K.K. (Japan)
16. RESEARCH METHODOLOGY
17. KEY ASSUMPTIONS AND ACRONYMS
2. GLOBAL DIGITAL PATHOLOGY MARKET INTRODUCTION
2.1. Global Digital Pathology Market– Taxonomy
2.2. Global Digital Pathology Market–Definitions
2.2.1. Product Type
2.2.2. Application
3. GLOBAL DIGITAL PATHOLOGY MARKET DYNAMICS
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Digital Pathology Market Dynamics – Factors Impact Analysis
3.6. Global Digital Pathology Market– Regulations
3.6.1. U.S
3.6.2. Europe
3.6.3. Japan
4. GLOBAL DIGITAL PATHOLOGY MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023
4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis
5. GLOBAL DIGITAL PATHOLOGY MARKET, BY PRODUCT TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023
5.1. Scanners
5.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Software
5.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Communication Systems
5.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Storage Systems
5.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
6. GLOBAL DIGITAL PATHOLOGY MARKET FORECAST, BY APPLICATION, 2012 - 2016 AND FORECAST, 2017 - 2023
6.1. Teleconsultation
6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Disease Diagnosis
6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Drug Discovery
6.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
7. GLOBAL DIGITAL PATHOLOGY MARKET FORECAST, BY TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023
7.1. Human Digital Pathology
7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Animal Digital Pathology
7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
8. GLOBAL DIGITAL PATHOLOGY MARKET FORECAST, BY END USER, 2012 - 2016 AND FORECAST, 2017 - 2023
8.1. Hospitals
8.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Pharmaceutical companies
8.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Academic institutes
8.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
9. GLOBAL DIGITAL PATHOLOGY MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 - 2023
9.1. North America
9.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Digital Pathology Market- Opportunity Analysis Index - By Product Type, By Application, By Type, By End User, and Region, 2017 – 2023
10. NORTH AMERICA DIGITAL PATHOLOGY MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
10.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1.1. Scanners
10.1.1.2. Software
10.1.1.3. Communication Systems
10.1.1.4. Storage Systems
10.1.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.2.1. Teleconsultation
10.1.2.2. Disease Diagnosis
10.1.2.3. Drug Discovery
10.1.3. Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.3.1. Human Digital Pathology
10.1.3.2. Animal Digital Pathology
10.1.4. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.4.1. Hospitals
10.1.4.2. Pharmaceutical companies
10.1.4.3. Academic institutes
10.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.1.5.1. U.S.
10.1.5.2. Canada
10.1.6. North America Digital Pathology Market- Opportunity Analysis Index - By Product Type, By Application, By Technology, By End User, and Country, 2017 – 2023
10.1.7. North America Digital Pathology Market Dynamics – Trends
11. EUROPE DIGITAL PATHOLOGY MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
11.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1.1. Scanners
11.1.1.2. Software
11.1.1.3. Communication Systems
11.1.1.4. Storage Systems
11.1.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.2.1. Teleconsultation
11.1.2.2. Disease Diagnosis
11.1.2.3. Drug Discovery
11.1.3. Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.3.1. Human Digital Pathology
11.1.3.2. Animal Digital Pathology
11.1.4. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.4.1. Hospitals
11.1.4.2. Pharmaceutical companies
11.1.4.3. Academic institutes
11.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.5.1. Germany
11.1.5.2. UK
11.1.5.3. France
11.1.5.4. Spain
11.1.5.5. Italy
11.1.5.6. Russia
11.1.5.7. Poland
11.1.5.8. Rest of Europe
11.1.6. Europe Digital Pathology Market- Opportunity Analysis Index - By Product Type, By Application Type, By Technology, By End User, and Country, 2017 – 2023
11.1.7. Europe Digital Pathology Market Dynamics – Trends
12. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
12.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1.1. Scanners
12.1.1.2. Software
12.1.1.3. Communication Systems
12.1.1.4. Storage Systems
12.1.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.2.1. Teleconsultation
12.1.2.2. Disease Diagnosis
12.1.2.3. Drug Discovery
12.1.3. Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.3.1. Human Digital Pathology
12.1.3.2. Animal Digital Pathology
12.1.4. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.4.1. Hospitals
12.1.4.2. Pharmaceutical companies
12.1.4.3. Academic institutes
12.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn),
Y-o-Y Growth (%), and Market Share (%)
12.1.5.1. Japan
12.1.5.2. China
12.1.5.3. India
12.1.5.4. ASEAN
12.1.5.5. Australia & New Zealand
12.1.5.6. Rest of Asia-Pacific
12.1.6. Asia-Pacific Digital Pathology Market- Opportunity Analysis Index - By Product Type, By Application Type, By Technology, By End User, and Country, 2017 – 2023
12.1.7. Asia-Pacific Digital Pathology Market Dynamics – Trends
13. LATIN AMERICA DIGITAL PATHOLOGY MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
13.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1.1. Scanners
13.1.1.2. Software
13.1.1.3. Communication Systems
13.1.1.4. Storage Systems
13.1.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.2.1. Teleconsultation
13.1.2.2. Disease Diagnosis
13.1.2.3. Drug Discovery
13.1.3. Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.3.1. Human Digital Pathology
13.1.3.2. Animal Digital Pathology
13.1.4. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.4.1. Hospitals
13.1.4.2. Pharmaceutical Companies
13.1.4.3. Academic Institutes
13.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.5.1. Brazil
13.1.5.2. Mexico
13.1.5.3. Argentina
13.1.5.4. Venezuela
13.1.5.5. Rest of Latin America
13.1.6. Latin America Digital Pathology Market- Opportunity Analysis Index - By Product Type, By Application Type, By Technology, By End User, and Country, 2017 – 2023
13.1.7. Latin America Digital Pathology Market Dynamics – Trends
14. MIDDLE EAST & AFRICA DIGITAL PATHOLOGY MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
14.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1.1. Scanners
14.1.1.2. Software
14.1.1.3. Communication Systems
14.1.1.4. Storage Systems
14.1.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.1.2.1. Teleconsultation
14.1.2.2. Disease Diagnosis
14.1.2.3. Drug Discovery
14.1.3. Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.1.3.1. Human Digital Pathology
14.1.3.2. Animal Digital Pathology
14.1.4. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.1.4.1. Hospitals
14.1.4.2. Pharmaceutical companies
14.1.4.3. Academic institutes
14.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.5.1. Gulf Cooperation Council (GCC) Countries
14.1.5.2. Israel
14.1.5.3. South Africa
14.1.5.4. Rest of MEA
14.1.6. MEA Digital Pathology Market- Opportunity Analysis Index - By Product Type, By Application, By Technology, By End User, and Country, 2017 – 2023
14.1.7. MEA Digital Pathology Market Dynamics – Trends
15. COMPETITION LANDSCAPE
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Drug & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Perkin Elmer, Inc. (U.S.)
15.2.2. Olympus Corporation (Japan)
15.2.3. Sectra AB (Sweeden)
15.2.4. GE Healthcare (U.K.)
15.2.5. Inspirata Co. (U.S.)
15.2.6. The Danaher Corporation (U.S.)
15.2.7. Koninklijke Philips N.V (Netherlands)
15.2.8. F. Hoffmann-La Roche AG (Switzerland)
15.2.9. Digipath Co. (U.S.)
15.2.10. Carl Zeiss AG (Germany)
15.2.11. 3D-Histech Ltd. (Hungary)
15.2.12. Yokogawa Electronic Corporation (Japan)
15.2.13. Quorum Technologies Inc. (Canada)
15.2.14. Hamamatsu Photonics K.K. (Japan)
16. RESEARCH METHODOLOGY
17. KEY ASSUMPTIONS AND ACRONYMS